6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
1h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
2h ago	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
4h ago	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
11h ago	Buffalo Potash Files Annual Information Form and New Technical Report
12h ago	Ionik Announces 30-Day Extension of Senior Debt Facility

About

38.51EUR-0.40 -1.03%

Closed • Updated at 15:17 GMT+00:00

Market Cap$43.95B

Volume1.78M

Beta1.01

RSI49.63

Gross Margin59.32%

Health TechnologyPharmaceuticals: Major

Bayer Ag — investor relations, events, news, and company updates on 6ix.

Latest News

Bayer : Kerendia™ approved in China for new indication in adult patients with heart failure with LVEF ≥40%

Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026

ASCO 2026: Bayer to Present New Data Across Oncology Portfolio

Bayer’s KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type 1 Diabetes and Chronic Kidney Disease

Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack

Community Chat

Ask AI